US Patent Issued to SpyGlass Pharma, The Regents of the University of Colorado on Jan. 27 for "Ophthalmic device for drug delivery" (California, Colorado Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,257, issued on Jan. 27, was assigned to SpyGlass Pharma Inc. (Aliso Viejo, Calif.) and The Regents of the University of Colorado (Denver).

"Ophthalmic device for drug delivery" was invented by Malik Y. Kahook (Denver), Glenn Sussman (Laguna Niguel, Calif.) and Craig Alan Cable II (Laguna Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An ophthalmic implant for drug delivery. The implant includes a primary intracapsular device coupled to a secondary device, wherein, when implanted in a patient's eye, the primary intracapsular device is held in place by the patient's capsular bag and the secondary device is held in place by the primary in...